Cargando…

Anemia in children with JIA: is it really driven by hepcidin level, or by a set of factors of a chronic disease

Detalles Bibliográficos
Autores principales:	Egorov, Andrey, Chasnyk, Vyacheslav, Kostik, Mikhail, Snegireva, Ludmila, Kalashnikova, Olga, Dubko, Margarita, Masalova, Vera, Likhacheva, Tatyana, Fedorova, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191184/ http://dx.doi.org/10.1186/1546-0096-12-S1-P187

Ejemplares similares

Identification of the best cut-off points and clinical signs specific for early recognition of macrophage activation syndrome in active systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2014)

PReS-FINAL-2233: Retrospective analysis of different treatment strategies in chronic non-bacterial osteomyelitis
por: Kostik, MM, et al.
Publicado: (2013)

PReS-FINAL-2154: The early predictors of fatal outcome of macrophage activation syndrome in pediatric rheumatic diseases
por: Kostik, MM, et al.
Publicado: (2013)

Rituximab Biosimilar BCD020 Shows Superior Efficacy above Conventional Non-Biologics Treatment in Pediatric Lupus Nephritis: The Data of Retrospective Cohort Study
por: Kostik, Mikhail, et al.
Publicado: (2023)

Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis
por: Kostik, Mikhail M, et al.
Publicado: (2015)

The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Uveitis Is a Risk Factor for Juvenile Idiopathic Arthritis' Significant Flare in Patients Treated With Biologics
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Interleukine-6 and TNFα blockers provide only partial and short-term temporal improvement in cryopyrin-associated periodic syndrome
por: Dolgikh, Vladimir, et al.
Publicado: (2014)

Distinguishing Between Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children and the Kawasaki Disease: Development of Preliminary Criteria Based on the Data of the Retrospective Multicenter Cohort Study
por: Kostik, Mikhail M., et al.
Publicado: (2021)

Comparison of different treatment approaches in chronic non-bacterial osteomyelitis.
por: Kostik, M, et al.
Publicado: (2015)

Differences in disease activity in cryopyrin-associated periodic syndrome in mutation-positive and mutation-negative patients
por: Kostik, M, et al.
Publicado: (2015)

Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data
por: Kostik, Mikhail M., et al.
Publicado: (2022)

Hepcidin and sports anemia
por: Kong, Wei-Na, et al.
Publicado: (2014)

COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report
por: Belozerov, Konstantin E., et al.
Publicado: (2023)

Determination of Risk Factors for Severe Life-Threatening Course of Multisystem Inflammatory Syndrome Associated with COVID-19 in Children
por: Avrusin, Ilia S., et al.
Publicado: (2023)

Iron, anemia and hepcidin in malaria
por: Spottiswoode, Natasha, et al.
Publicado: (2014)

P03-006 - Pamidronate rapidly decreases CRP and TNFΑ in CNO
por: Kostik, MM, et al.
Publicado: (2013)

Role of hepcidin in the pathophysiology and diagnosis of anemia
por: D'Angelo, Guido
Publicado: (2013)

Hepcidin and Anemia: A Tight Relationship
por: Pagani, Alessia, et al.
Publicado: (2019)

Effect of Interleukin and Hepcidin in Anemia of Chronic Diseases
por: Yacoub, Maha F., et al.
Publicado: (2020)

Targeting the Hepcidin-Ferroportin Axis in the Diagnosis and Treatment of Anemias
por: Nemeth, Elizabeta
Publicado: (2010)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
por: Poli, Maura, et al.
Publicado: (2017)

Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
por: Huang, Ying-Hsien, et al.
Publicado: (2017)

Role of Hepcidin in Anemia of Chronic Disease in Rheumatoid Arthritis
por: Nita, Eleni, et al.
Publicado: (2021)

Study of the hepcidin level in pregnant women with and without anemia
por: Aringazina, Raisa, et al.
Publicado: (2023)

Hepcidin and iron parameters in children with anemia of chronic disease and iron deficiency anemia
por: Mahajan, Gunjan, et al.
Publicado: (2017)

Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia
por: Mirciov, Cornel S. G., et al.
Publicado: (2017)

The Levels of Hepcidin and Erythropoietin in Pregnant Women with Anemia of Various Geneses
por: Vazenmiller, Dmitriy, et al.
Publicado: (2018)

A role for hepcidin in the anemia caused by Trypanosoma brucei infection
por: Neves, João V., et al.
Publicado: (2020)

Changes in Hepcidin Levels in an Animal Model of Anemia of Chronic Inflammation: Mechanistic Insights Related to Iron Supplementation and Hepcidin Regulation
por: Kim, Hye-Bin, et al.
Publicado: (2021)

The association of hepcidin, reticulocyte hemoglobin equivalent and anemia-related indicators on anemia in chronic kidney disease
por: Gao, Zhaoli, et al.
Publicado: (2023)

Understanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease
por: Larson, Derek S., et al.
Publicado: (2013)

Epidemiology of JIA
por: Lahdenne, Pekka
Publicado: (2014)

The relationship between anemia, liver disease, and hepcidin levels in hemodialysis patients with hepatitis
por: Zumrutdal, A., et al.
Publicado: (2012)

A Comprehensive Analysis of the Erythropoietin-erythroferrone-hepcidin Pathway in Hereditary Hemolytic Anemias
por: van Vuren, Annelies J., et al.
Publicado: (2021)

The Key Role of Hepcidin-25 in Anemia in Multiple Myeloma Patients with Renal Impairment
por: Banaszkiewicz, Małgorzata, et al.
Publicado: (2022)

GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease
por: Farag, Naglaa Makram, et al.
Publicado: (2023)

Trajectories of disease courses in the inception cohort of newly diagnosed patients with JIA (ICON-JIA): the potential of serum biomarkers at baseline
por: Ganeva, Margarita, et al.
Publicado: (2021)

Inflammation-induced hepcidin-25 is associated with the development of anemia in septic patients: an observational study
por: van Eijk, Lucas T, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d8kns898v773dbh83eb0kuj2lq